Johnson & Johnson Reports Q1 2025 Results

Johnson & Johnson’s MedTech Division posts solid Q1 growth

$8 billion division grew 4.1% for the quarter

J&J Flexes Its Financial 'Bicep,' Hiking Guidance Despite Tariff Headwinds

Johnson & Johnson stock fell alongside the broader market, despite beating first-quarter calls and hiking its 2025 sales guidance. The post J&J Flexes Its Financial 'Bicep,' Hiking Guidance Despite Tariff Headwinds appeared first on Investor's Business Daily.

Earnings Snapshot: J&J tops Q1 estimates; raises FY sales guidance

Earnings Snapshot: Johnson & Johnson tops Q1 estimates; raises FY sales guidance

Johnson & Johnson: Q1 Earnings Snapshot

NEW BRUNSWICK, N.J. (AP) — NEW BRUNSWICK, N.J. (AP) — Johnson & Johnson (JNJ) on Tuesday reported first-quarter profit of $11 billion.

Johnson & Johnson Reports Q1 2025 Results

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Apr 15, 2025-

Stenger Family Office LLC Takes $2.16 Million Position in Johnson & Johnson (NYSE:JNJ)

Stenger Family Office LLC bought a new stake in Johnson & Johnson (NYSE:JNJ – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 14,921 shares of the company’s stock, valued at approximately $2,158,000. A number of other institutional investors have also bought and sold shares of the company. Oregon Pacific Wealth Management LLC bought a n…